Septerna, Inc. has grown revenue 1644% a year over three years and 1644% a year over five. Revenue growth, 3-year annual rate: +1644% (Biotechnology median +17%). Revenue growth, 5-year rate: +1644%, growth has slowed since the five-year average. Years of annual history on file: 3, FY2023 to FY2025, as filed.

SEPNSepterna, Inc.

Healthcare

$38.32+144% 1Y

$38.32

$16.0052 weeks$48.13

Is it growing?

Good

Growing: revenue growing +13520% year on year and operating margin widening (+15121.7 points).

2 good, 1 without data

Revenue trend+13520% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Margin direction+15121.7 points operating

Trailing-twelve-month operating margin, -41.8% now against -15163.6% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is SEPN growing?

Septerna, Inc. has grown revenue 1644% a year over three years and 1644% a year over five.

+1644%

Revenue growth, 3-year annual rate · Biotechnology median +17% · compounding fast · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: +1644%
Revenue growth, 5-year rate · +1644% over three · growth has slowed since the five-year average
Years of annual history on file: 3
Years of annual history on file · FY2023 to FY2025, as filed

Details›